BioPharma Services Inc. is a full-service Contract Research Organization (CRO) specializing in Phase I/IIa, Bioequivalence, Human Abuse Liability, PET Imaging, and Psychedelic Studies. With over 17 years of industry experience and a state-of-the-art research facility in Toronto, Canada, we are committed to delivering high-quality clinical research with speed, efficiency, and compliance. AI-Driven Patient Recruitment & Expanded Capabilities: Through our connection with WELL Health Technologies, BioPharma now leverages AI-powered analytics to accelerate and optimize patient recruitment. By analyzing real-world clinical data, we can rapidly identify eligible participants, improving enrollment timelines while maintaining strict ethical and regulatory standards. Our in-house GLP/GCP bioanalytical services, featuring LC-MS/MS technology, provide high-precision analysis to support both preclinical and clinical research. BioPharma remains fully compliant with FDA, Health Canada, and ANVISA regulations and has successfully passed all major regulatory inspections. Key Highlights ✔ 150+ bed capacity in a cutting-edge Toronto-based clinical facility ✔ AI-enhanced recruitment ensures 99% enrollment for all Phase I studies with a 95% completion rate ✔ Accelerated study startup: 30-Day CTA approval, Weekly IRB/Ethics review ✔ 20,000+ active subject database, including special populations & healthy volunteers ✔ Full-service CRO: Regulatory Affairs, Scientific & Medical Expertise, Project Management, Biostatistical Analysis (CDISC-compliant SDTM & ADaM datasets), Medical Writing, and more At BioPharma Services, we combine industry expertise, AI-driven recruitment, and operational excellence to deliver timely, reliable, and high-quality clinical research for our global clients.